http://www.pharmaceutical-technology.com/news/accord-commercialise-hipra-covid-19-vaccine-uk/
Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently said it seeks vaccines designed against XBB 1.5 Omicron.
Create an account
or login to join the discussion